Edition:
United States

Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jul 20 2017

AbbVie loses bid to overturn $15 million Depakote injury verdict

A federal judge has rejected AbbVie Inc's bid to overturn a $15 million verdict for a 10-year-old boy whose mother blamed his birth defect on its bipolar disorder drug Depakote, which she took while she was pregnant.

Jul 20 2017

Momenta seeks $938 million from Amphastar at drug patent trial's end

A lawyer for Momenta Pharmaceuticals Inc urged a federal jury on Thursday to force Amphastar Pharmaceuticals Inc to pay $938 million for infringing a patent the drugmaker held through its production of a generic version of the blood-thinner Lovenox.

Jul 20 2017

Ex-Ariad employee's husband charged with insider trading

BOSTON The operator of a Massachusetts-based medical marijuana consultation practice was arrested on Thursday on charges that he engaged in insider trading based on information he learned from his wife, a former employee of Ariad Pharmaceuticals Inc.

Jul 20 2017

Ex-Ariad employee's husband charged with insider trading

BOSTON The operator of a Massachusetts-based medical marijuana consultation practice was arrested on Thursday on charges that he engaged in insider trading based on information he learned from his wife, a former employee of Ariad Pharmaceuticals Inc.

Jul 20 2017

Ex-Akebia employee faces losing bail in insider trading case

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

Jul 20 2017

Ex-Akebia employee faces losing bail in insider trading case

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

Jul 20 2017

Ex-Credit Suisse banker pleads guilty in U.S. offshore tax case

July 20 A former Credit Suisse Group AG banker from Switzerland pleaded guilty on Wednesday to participating in a wide-ranging scheme to help Americans hide millions of dollars in offshore accounts to evade U.S. taxes.

Jul 19 2017

Ex-Credit Suisse banker pleads guilty in U.S. offshore tax case

A former Credit Suisse Group AG banker from Switzerland pleaded guilty on Wednesday to participating in a wide-ranging scheme to help Americans hide millions of dollars in offshore accounts to evade U.S. taxes.

Jul 19 2017

Russian sentenced in U.S. to five years prison for 'Citadel' malware

A Russian man who U.S. prosecutors say played a role in developing the sophisticated malware known as "Citadel" used to steal personal financial information from thousands of computers worldwide was sentenced on Wednesday to five years in prison.

Jul 18 2017

Chicago U.S. attorney's office launches healthcare fraud unit

The top federal prosecutor in Chicago announced on Tuesday that his office was creating a new unit dedicated to pursuing criminal healthcare fraud cases as part of an effort to bring a greater focus to the area.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary